1. Home
  2. AXR vs ACOG Comparison

AXR vs ACOG Comparison

Compare AXR & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXR
  • ACOG
  • Stock Information
  • Founded
  • AXR 1961
  • ACOG 2000
  • Country
  • AXR United States
  • ACOG Canada
  • Employees
  • AXR N/A
  • ACOG N/A
  • Industry
  • AXR Homebuilding
  • ACOG
  • Sector
  • AXR Real Estate
  • ACOG
  • Exchange
  • AXR Nasdaq
  • ACOG Nasdaq
  • Market Cap
  • AXR 127.3M
  • ACOG 130.9M
  • IPO Year
  • AXR N/A
  • ACOG N/A
  • Fundamental
  • Price
  • AXR $21.52
  • ACOG $6.02
  • Analyst Decision
  • AXR
  • ACOG Strong Buy
  • Analyst Count
  • AXR 0
  • ACOG 1
  • Target Price
  • AXR N/A
  • ACOG $18.00
  • AVG Volume (30 Days)
  • AXR 6.8K
  • ACOG 109.4K
  • Earning Date
  • AXR 12-12-2025
  • ACOG 11-13-2025
  • Dividend Yield
  • AXR N/A
  • ACOG N/A
  • EPS Growth
  • AXR 40.98
  • ACOG N/A
  • EPS
  • AXR 2.48
  • ACOG N/A
  • Revenue
  • AXR $48,454,000.00
  • ACOG $7,427,199.00
  • Revenue This Year
  • AXR $28.57
  • ACOG N/A
  • Revenue Next Year
  • AXR N/A
  • ACOG $101.16
  • P/E Ratio
  • AXR $8.74
  • ACOG N/A
  • Revenue Growth
  • AXR N/A
  • ACOG N/A
  • 52 Week Low
  • AXR $17.60
  • ACOG $3.75
  • 52 Week High
  • AXR $39.68
  • ACOG $11.54
  • Technical
  • Relative Strength Index (RSI)
  • AXR 50.72
  • ACOG 45.34
  • Support Level
  • AXR $19.69
  • ACOG $5.66
  • Resistance Level
  • AXR $21.32
  • ACOG $6.20
  • Average True Range (ATR)
  • AXR 1.02
  • ACOG 0.50
  • MACD
  • AXR 0.20
  • ACOG 0.07
  • Stochastic Oscillator
  • AXR 70.81
  • ACOG 64.38

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: